BioLargo (BLGO) Financial Statements

Compare

68 Followers

BioLargo Financial Overview

BioLargo's market cap is currently $52.57M. The company's EPS TTM is $-0.012; its P/E ratio is -4.80; BioLargo is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	$ 7.76M	$ 17.78M	$ 12.23M	$ 5.88M	$ 2.53M
Gross Profit	$ 3.41M	$ 7.85M	$ 6.15M	$ 2.86M	$ 1.10M
Operating Income	$ -14.84M	$ -4.33M	$ -4.19M	$ -5.12M	$ -6.38M
EBITDA	$ -14.55M	$ -4.06M	$ -4.19M	$ -5.10M	$ -6.70M
Net Income	$ -11.78M	$ -2.40M	$ -3.50M	$ -4.50M	$ -7.38M
Balance Sheet
Cash & Short-Term Investments	$ 3.88M	$ 3.55M	$ 3.54M	$ 1.85M	$ 962.00K
Total Assets	$ 8.31M	$ 10.51M	$ 8.21M	$ 4.86M	$ 3.02M
Total Debt	$ 3.51M	$ 2.55M	$ 1.70M	$ 1.47M	$ 1.13M
Net Debt	$ -370.00K	$ -994.00K	$ -1.84M	$ -383.00K	$ 171.00K
Total Liabilities	$ 6.79M	$ 4.46M	$ 4.00M	$ 2.85M	$ 2.09M
Stockholders' Equity	$ 4.04M	$ 8.85M	$ 6.84M	$ 4.88M	$ 4.65M
Cash Flow
Free Cash Flow	$ -8.34M	$ -4.44M	$ -2.84M	$ -3.03M	$ -3.97M
Operating Cash Flow	$ -8.30M	$ -3.21M	$ -2.37M	$ -2.76M	$ -3.94M
Investing Cash Flow	$ 435.00K	$ -1.32M	$ -478.00K	$ -271.00K	$ -34.00K
Financing Cash Flow	$ 8.22M	$ 4.44M	$ 4.66M	$ 3.96M	$ 4.23M

Currency in USD

BioLargo Earnings and Revenue History

Income Statement >

BioLargo Debt to Assets

Balance Sheet >

BioLargo Cash Flow

Cash Flow >

BioLargo Forecast EPS vs Actual EPS

Earnings >